Palopegteriparatide |
ACP-014; ACP014; ACP 014 |
Approved |
Ascendis Pharma |
TransCon, YORVIPATH |
EU |
Hypoparathyroidism |
Ascendis Pharma, Ascendis Pharma Bone Diseases As |
2023-11-17 |
Hypoparathyroidism |
Details
|
Teriparatide biosimilar (Biosidus) |
rhPTH (1-34) (Biosidus) |
Approved |
Biosidus |
Osteofortil |
Argentina |
Osteoporosis |
Biosidus |
2012-08-01 |
Osteoporosis |
Details
|
Abaloparatide |
ITM-058; BA-058-SC; BA-058-TD; BIM-44058; BA-058 |
Approved |
Ipsen |
ELADYNOS, Tymlos |
United States |
Osteoporosis, Postmenopausal |
Radius Health Inc |
2017-04-28 |
Osteoporotic Fractures; Osteoporosis; Osteoporosis, Postmenopausal; Intervertebral Disc Degeneration; Fractures, Bone |
Details
|
Teriparatide biosimilar (Amega Biotech) |
rhPTH (1-34) (Amega Biotech) |
Approved |
Amega Biotech |
|
|
|
|
|
Osteoporosis |
Details
|
Teriparatide biosimilar (Pfenex) |
rhPTH (1-34) (Pfenex); PF-708 |
Approved |
Pfenex Biopharmaceuticals Inc |
Bonsity, Qutavina |
United States |
Osteoporosis, Postmenopausal; Glucocorticoid-induced osteoporosis; Osteoporosis |
Alvogen |
2019-10-04 |
Osteoporosis; Osteoporosis, Postmenopausal; Glucocorticoid-induced osteoporosis |
Details
|
Teriparatide |
MN-10T; LY 333334; hPTH-1-34; EB-613 |
Approved |
Eli Lilly And Company |
Forteo, Forsteo, 复泰奥 |
United States |
Osteoporosis |
Eli Lilly And Company |
2002-11-26 |
Ankle Fractures; Chronic Kidney Disease-Mineral and Bone Disorder; Anorexia Nervosa; Hypoparathyroidism; Periodontitis; Fractures, Bone; Osteoarthritis, Knee; Back Pain; Spinal Fractures; Humeral Fractures; Femoral Neck Fractures; Cartilage Diseases; Hypocalcemia; Colles' Fracture; Osteoporosis, Postmenopausal; Menopausal symptoms; Spinal Cord Injuries; Bone Diseases, Metabolic; Osteoporosis; Alveolar Bone Loss; Hyperparathyroidism, Secondary; Drug-Related Side Effects and Adverse Reactions |
Details
|
Parathyroid hormone (Shire) |
NPSP-795; rhPTH (1-84); rhPTH-1-84; PTH (1-84); SB-423562; PTH 1-84; NPSP-558; SHP-635; SHP-634; ALX-111; 423562; EBP-05; EB-612 |
Approved |
Shire |
Natpara, Preotact, Natpar |
United States |
Hypoparathyroidism |
Nps Pharmaceuticals, Inc |
2006-04-24 |
Osteoporosis; Bone Diseases, Endocrine; Osteoporosis, Postmenopausal; Hypocalcemia; Psoriasis; Hypoparathyroidism; Hyperparathyroidism |
Details
|
Teriparatide biosimilar (Intas Pharmaceuticals) |
rhPTH (1-34) (Intas Pharmaceuticals); INTG8; INTG-8 |
Approved |
Intas Biopharmaceuticals |
Terifrac |
India |
Osteoporosis |
Intas Biopharmaceuticals |
2010-12-01 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Gedeon Richter) |
rhPTH (1-34) (Gedeon Richter) |
Approved |
Gedeon Richter Plc |
Terrosa |
EU |
Osteoporosis |
Gedeon Richter Plc |
2017-01-04 |
Osteoporosis; Fractures, Stress |
Details
|
Teriparatide biosimilar (Salubris) |
SAL056; G56-W1; SAL-001 |
Approved |
Shenzhen Salubris Pharmaceuticals Co Ltd |
欣复泰 |
Mainland China |
Osteoporosis, Postmenopausal |
Suzhou Genemen Biotech Co Ltd |
2019-09-29 |
Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (USV) |
|
Approved |
Usv Ltd |
|
|
|
|
|
Osteoporosis |
Details
|
Teriparatide biosimilar (Strides Pharma) |
SBL-001 |
Approved |
Strides Pharma |
Kauliv |
EU |
Osteoporosis; Osteoporosis, Postmenopausal |
Strides Pharma (Cyprus) Ltd |
2023-01-12 |
Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (STADA Arzneimittel AG) |
rhPTH (1-34) (STADA Arzneimittel AG) |
Approved |
Stada Arzneimittel Ag |
Movymia |
EU |
Osteoporosis |
Stada Arzneimittel Ag |
2017-01-11 |
Osteoporosis |
Details
|
Recombinant parathyroid hormone biosimilar(Chongqing Fujin Biological Medicine) |
|
Approved |
Chongqing Fujin Biological Medicine Co Ltd |
|
|
|
|
|
|
Details
|
Recombinant Human Parathyroid Hormone (1-34), Shanghai Fosunpharma |
|
Approved |
Shanghai Fosun Pharmaceutical (Group) Co Ltd |
|
|
|
|
|
|
Details
|
Teriparatide acetate |
hPTH (1-34) acet. H2O; AK-159; MN-10-T |
Approved |
Union Square Ventures Llc |
Parathar, Teribone |
Japan |
Osteoporosis; Hypocalcemia |
null |
1987-03-31 |
Osteoporosis; Hypocalcemia |
Details
|
Teriparatide biosimilar (Theramex) |
|
Approved |
Theramex Ireland Ltd |
Livogiva |
EU |
Osteoporosis |
Theramex Ireland Ltd |
2020-08-27 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Shanghai United Cell ) |
|
Approved |
Shanghai United Cell Biotechnology Co Ltd |
|
Mainland China |
Osteoporosis |
Shanghai United Cell Biotechnology Co Ltd |
2017-03-22 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Beijing Bokangjian Gene) |
|
Approved |
Beijing Genetech Pharmaceutical Co Ltd |
博固泰 |
Mainland China |
Osteoporosis |
Beijing Genetech Pharmaceutical Co Ltd |
2024-01-16 |
Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (Virchow/Sun) |
rhPTH (1-34) (Virchow/Sun) |
Approved |
Sun Pharmaceutical Industries Ltd, Virchow Group |
Bonista, Osteotide |
EU |
Osteoporosis; Osteoporosis, Postmenopausal |
Sun Pharmaceutical Industries (Europe) Bv |
|
Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (CinnaGen) |
rhPTH (1-34) (CinnaGen) |
Approved |
Cinnagen |
CinnoPar |
Iran |
Osteoporosis |
Cinnagen |
2013-01-01 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Zydus Cadila) |
rhPTH (1-34) (Zydus Cadila) |
Approved |
Zydus Cadila |
|
India |
Osteoporosis |
Zydus Cadila |
2014-01-01 |
Osteoporosis |
Details
|
Palopegteriparatide |
ACP-014; ACP014; ACP 014 |
Approved |
Ascendis Pharma |
TransCon, YORVIPATH |
EU |
Hypoparathyroidism |
Ascendis Pharma, Ascendis Pharma Bone Diseases As |
2023-11-17 |
Hypoparathyroidism |
Details
|
Teriparatide biosimilar (Biosidus) |
rhPTH (1-34) (Biosidus) |
Approved |
Biosidus |
Osteofortil |
Argentina |
Osteoporosis |
Biosidus |
2012-08-01 |
Osteoporosis |
Details
|
Abaloparatide |
ITM-058; BA-058-SC; BA-058-TD; BIM-44058; BA-058 |
Approved |
Ipsen |
ELADYNOS, Tymlos |
United States |
Osteoporosis, Postmenopausal |
Radius Health Inc |
2017-04-28 |
Osteoporotic Fractures; Osteoporosis; Osteoporosis, Postmenopausal; Intervertebral Disc Degeneration; Fractures, Bone |
Details
|
Teriparatide biosimilar (Amega Biotech) |
rhPTH (1-34) (Amega Biotech) |
Approved |
Amega Biotech |
|
|
|
|
|
Osteoporosis |
Details
|
Teriparatide biosimilar (Pfenex) |
rhPTH (1-34) (Pfenex); PF-708 |
Approved |
Pfenex Biopharmaceuticals Inc |
Bonsity, Qutavina |
United States |
Osteoporosis, Postmenopausal; Glucocorticoid-induced osteoporosis; Osteoporosis |
Alvogen |
2019-10-04 |
Osteoporosis; Osteoporosis, Postmenopausal; Glucocorticoid-induced osteoporosis |
Details
|
Teriparatide |
MN-10T; LY 333334; hPTH-1-34; EB-613 |
Approved |
Eli Lilly And Company |
Forteo, Forsteo, 复泰奥 |
United States |
Osteoporosis |
Eli Lilly And Company |
2002-11-26 |
Ankle Fractures; Chronic Kidney Disease-Mineral and Bone Disorder; Anorexia Nervosa; Hypoparathyroidism; Periodontitis; Fractures, Bone; Osteoarthritis, Knee; Back Pain; Spinal Fractures; Humeral Fractures; Femoral Neck Fractures; Cartilage Diseases; Hypocalcemia; Colles' Fracture; Osteoporosis, Postmenopausal; Menopausal symptoms; Spinal Cord Injuries; Bone Diseases, Metabolic; Osteoporosis; Alveolar Bone Loss; Hyperparathyroidism, Secondary; Drug-Related Side Effects and Adverse Reactions |
Details
|
Parathyroid hormone (Shire) |
NPSP-795; rhPTH (1-84); rhPTH-1-84; PTH (1-84); SB-423562; PTH 1-84; NPSP-558; SHP-635; SHP-634; ALX-111; 423562; EBP-05; EB-612 |
Approved |
Shire |
Natpara, Preotact, Natpar |
United States |
Hypoparathyroidism |
Nps Pharmaceuticals, Inc |
2006-04-24 |
Osteoporosis; Bone Diseases, Endocrine; Osteoporosis, Postmenopausal; Hypocalcemia; Psoriasis; Hypoparathyroidism; Hyperparathyroidism |
Details
|
Teriparatide biosimilar (Intas Pharmaceuticals) |
rhPTH (1-34) (Intas Pharmaceuticals); INTG8; INTG-8 |
Approved |
Intas Biopharmaceuticals |
Terifrac |
India |
Osteoporosis |
Intas Biopharmaceuticals |
2010-12-01 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Gedeon Richter) |
rhPTH (1-34) (Gedeon Richter) |
Approved |
Gedeon Richter Plc |
Terrosa |
EU |
Osteoporosis |
Gedeon Richter Plc |
2017-01-04 |
Osteoporosis; Fractures, Stress |
Details
|
Teriparatide biosimilar (Salubris) |
SAL056; G56-W1; SAL-001 |
Approved |
Shenzhen Salubris Pharmaceuticals Co Ltd |
欣复泰 |
Mainland China |
Osteoporosis, Postmenopausal |
Suzhou Genemen Biotech Co Ltd |
2019-09-29 |
Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (USV) |
|
Approved |
Usv Ltd |
|
|
|
|
|
Osteoporosis |
Details
|
Teriparatide biosimilar (Strides Pharma) |
SBL-001 |
Approved |
Strides Pharma |
Kauliv |
EU |
Osteoporosis; Osteoporosis, Postmenopausal |
Strides Pharma (Cyprus) Ltd |
2023-01-12 |
Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (STADA Arzneimittel AG) |
rhPTH (1-34) (STADA Arzneimittel AG) |
Approved |
Stada Arzneimittel Ag |
Movymia |
EU |
Osteoporosis |
Stada Arzneimittel Ag |
2017-01-11 |
Osteoporosis |
Details
|
Recombinant parathyroid hormone biosimilar(Chongqing Fujin Biological Medicine) |
|
Approved |
Chongqing Fujin Biological Medicine Co Ltd |
|
|
|
|
|
|
Details
|
Recombinant Human Parathyroid Hormone (1-34), Shanghai Fosunpharma |
|
Approved |
Shanghai Fosun Pharmaceutical (Group) Co Ltd |
|
|
|
|
|
|
Details
|
Teriparatide acetate |
hPTH (1-34) acet. H2O; AK-159; MN-10-T |
Approved |
Union Square Ventures Llc |
Parathar, Teribone |
Japan |
Osteoporosis; Hypocalcemia |
null |
1987-03-31 |
Osteoporosis; Hypocalcemia |
Details
|
Teriparatide biosimilar (Theramex) |
|
Approved |
Theramex Ireland Ltd |
Livogiva |
EU |
Osteoporosis |
Theramex Ireland Ltd |
2020-08-27 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Shanghai United Cell ) |
|
Approved |
Shanghai United Cell Biotechnology Co Ltd |
|
Mainland China |
Osteoporosis |
Shanghai United Cell Biotechnology Co Ltd |
2017-03-22 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Beijing Bokangjian Gene) |
|
Approved |
Beijing Genetech Pharmaceutical Co Ltd |
博固泰 |
Mainland China |
Osteoporosis |
Beijing Genetech Pharmaceutical Co Ltd |
2024-01-16 |
Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (Virchow/Sun) |
rhPTH (1-34) (Virchow/Sun) |
Approved |
Sun Pharmaceutical Industries Ltd, Virchow Group |
Bonista, Osteotide |
EU |
Osteoporosis; Osteoporosis, Postmenopausal |
Sun Pharmaceutical Industries (Europe) Bv |
|
Osteoporosis; Osteoporosis, Postmenopausal |
Details
|
Teriparatide biosimilar (CinnaGen) |
rhPTH (1-34) (CinnaGen) |
Approved |
Cinnagen |
CinnoPar |
Iran |
Osteoporosis |
Cinnagen |
2013-01-01 |
Osteoporosis |
Details
|
Teriparatide biosimilar (Zydus Cadila) |
rhPTH (1-34) (Zydus Cadila) |
Approved |
Zydus Cadila |
|
India |
Osteoporosis |
Zydus Cadila |
2014-01-01 |
Osteoporosis |
Details
|